UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study

PloS one, 2024-05, Vol.19 (5), p.e0304556

2024

Volltextzugriff (PDF)

Perceived Workplace Stress Is Associated with an Increased Risk of Prostate Cancer before Age 65

Frontiers in oncology, 2017-11, Vol.7, p.269-269

2017

Volltextzugriff (PDF)

COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19)

Cancers, 2023-09, Vol.15 (19), p.4777

2023

Volltextzugriff (PDF)

COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19)

Cancers, 2022-11, Vol.14 (22), p.5547

2022

Volltextzugriff (PDF)

Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients-First Results from the PAPESCO-19 Cohort Study

Cancers, 2021-07, Vol.13 (14), p.3389

2021

Volltextzugriff (PDF)

Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol

Clinical and translational radiation oncology, 2023-05, Vol.40, p.100613-100613, Article 100613

2023

Volltextzugriff (PDF)

COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19)

Clinical Medicine Insights. Oncology, 2022, Vol.16, p.11795549221090187-11795549221090187

2022

Volltextzugriff (PDF)

Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral Metastases

Biomedicines, 2020-11, Vol.8 (12), p.548

2020

Volltextzugriff (PDF)

Cognitive Disorders and Occupational Exposure to Organophosphates: Results From the PHYTONER Study

American journal of epidemiology, 2013-05, Vol.177 (10), p.1086-1096

2013

Volltextzugriff (PDF)

Occupational exposure to benzene, toluene, xylene and styrene and risk of prostate cancer in a population-based study

Occupational and environmental medicine (London, England), 2018-08, Vol.75 (8), p.562-572

2018

Volltextzugriff (PDF)

A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers

European journal of cancer (1990), 2020-11, Vol.140, p.37-44

2020

Volltextzugriff (PDF)

OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer

European urology, 2021-10, Vol.80 (4), p.405-414

2021

Volltextzugriff (PDF)

Socioeconomic background in relation to stage at diagnosis in women with breast cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10574-10574

2021

Volltextzugriff (PDF)

Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer

Journal of clinical oncology, 2022-11, Vol.40 (32), p.3699-3708

2022

Volltextzugriff (PDF)

Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada

BMC public health, 2015-09, Vol.15 (1), p.913-913, Article 913

2015

Volltextzugriff (PDF)

Lifetime report of perceived stress at work and cancer among men: A case-control study in Montreal, Canada

Preventive medicine, 2017-03, Vol.96, p.28-35

2017

Volltextzugriff (PDF)

O22-3Occupational exposure to chromium, nickel and cadmium, and prostate cancer risk and in a population-based case-control study in montreal, canada

Occupational and environmental medicine (London, England), 2016-09, Vol.73 (Suppl 1), p.A42-A42

2016

Volltextzugriff (PDF)

Prostate cancer with oligometastatic relapse: Combining stereotactic ablative radiotherapy and durvalumab, a randomized phase II trial (POSTCARD - GETUG-P13)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS5088-TPS5088

2019

Volltextzugriff (PDF)

0323 Occupational exposure to benzene, toluene, xylene and styrene, and risk of prostate cancer

Occupational and environmental medicine (London, England), 2017-08, Vol.74 (Suppl 1), p.A100

2017

Volltextzugriff (PDF)

Oligopelvis-GETUG P07: A multicenter phase II trial of combined salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses of prostate cancer

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.93-93

2020

Volltextzugriff (PDF)

Use of oral anticoagulants and risk of prostate cancer: a population-based case–control study in Montreal, Canada

Cancer causes & control, 2014-09, Vol.25 (9), p.1159-1166

2014

Volltextzugriff (PDF)

Levels and determinants of pesticide exposure in operators involved in treatment of vineyards: results of the PESTEXPO Study

Journal of exposure science & environmental epidemiology, 2012-11, Vol.22 (6), p.593-600

2012

Volltextzugriff (PDF)

Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: Results from the North-American case-control study Prostate Cancer & Environment Study

Urologic oncology, 2015-11, Vol.33 (11), p.494.e1-494.e7

2015

Volltextzugriff (PDF)

A French crop-exposure matrix for use in epidemiological studies on pesticides: PESTIMAT

Journal of exposure science & environmental epidemiology, 2017-01, Vol.27 (1), p.56-63

2017

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Cancer
(15)
Life Sciences
(14)
Humans
(13)
Oncology
(10)
Male
(9)
Middle Aged
(9)
Aged
(8)
Prostate Cancer
(8)
Public, Environmental & Occupational Health
(7)
Cancer Therapies
(6)
Epidemiology
(6)
Case-Control Studies
(5)
Covid-19
(5)
Exposure
(5)
Patients
(5)
Risk Factors
(5)
Adult
(4)
Cancer Patients
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study

Perceived Workplace Stress Is Associated with an Increased Risk of Prostate Cancer before Age 65

COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19)

COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19)

Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients-First Results from the PAPESCO-19 Cohort Study

Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol

COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19)

Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral Metastases

Cognitive Disorders and Occupational Exposure to Organophosphates: Results From the PHYTONER Study

Occupational exposure to benzene, toluene, xylene and styrene and risk of prostate cancer in a population-based study

A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers

OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer

Socioeconomic background in relation to stage at diagnosis in women with breast cancer

Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07)

Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer

Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada

Lifetime report of perceived stress at work and cancer among men: A case-control study in Montreal, Canada

O22-3Occupational exposure to chromium, nickel and cadmium, and prostate cancer risk and in a population-based case-control study in montreal, canada

Prostate cancer with oligometastatic relapse: Combining stereotactic ablative radiotherapy and durvalumab, a randomized phase II trial (POSTCARD - GETUG-P13)

0323 Occupational exposure to benzene, toluene, xylene and styrene, and risk of prostate cancer

Oligopelvis-GETUG P07: A multicenter phase II trial of combined salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses of prostate cancer

Use of oral anticoagulants and risk of prostate cancer: a population-based case–control study in Montreal, Canada

Levels and determinants of pesticide exposure in operators involved in treatment of vineyards: results of the PESTEXPO Study

Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: Results from the North-American case-control study Prostate Cancer & Environment Study

A French crop-exposure matrix for use in epidemiological studies on pesticides: PESTIMAT

Suchergebnisse filtern